Millar H - Search Results

1

Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.

Tang Y, Nakada MT, Rafferty P, Laraio J, McCabe FL, Millar H, Cunningham M, Snyder LA, Bugelski P, Yan L. Tang Y, et al. Among authors: millar h. Mol Cancer Res. 2006 Jun;4(6):371-7. doi: 10.1158/1541-7786.MCR-06-0042. Mol Cancer Res. 2006. PMID: 16778084

2

Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.

Tang Y, Nakada MT, Kesavan P, McCabe F, Millar H, Rafferty P, Bugelski P, Yan L. Tang Y, et al. Among authors: millar h. Cancer Res. 2005 Apr 15;65(8):3193-9. doi: 10.1158/0008-5472.CAN-04-3605. Cancer Res. 2005. PMID: 15833850

3

Alphav integrin-targeted immunoconjugates regress established human tumors in xenograft models.

Chen Q, Millar HJ, McCabe FL, Manning CD, Steeves R, Lai K, Kellogg B, Lutz RJ, Trikha M, Nakada MT, Anderson GM. Chen Q, et al. Clin Cancer Res. 2007 Jun 15;13(12):3689-95. doi: 10.1158/1078-0432.CCR-07-0026. Clin Cancer Res. 2007. PMID: 17575234

4

Circulating human interleukin-8 as an indicator of cancer progression in a nude rat orthotopic human non-small cell lung carcinoma model.

Millar HJ, Nemeth JA, McCabe FL, Pikounis B, Wickstrom E. Millar HJ, et al. Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2180-7. doi: 10.1158/1055-9965.EPI-07-2915. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18708412

5

CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models.

Ngo CV, Picha K, McCabe F, Millar H, Tawadros R, Tam SH, Nakada MT, Anderson GM. Ngo CV, et al. Among authors: millar h. Int J Cancer. 2007 Mar 15;120(6):1261-7. doi: 10.1002/ijc.22426. Int J Cancer. 2007. PMID: 17192924

6

CNTO 95, a fully human anti alphav integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells.

Chen Q, Manning CD, Millar H, McCabe FL, Ferrante C, Sharp C, Shahied-Arruda L, Doshi P, Nakada MT, Anderson GM. Chen Q, et al. Among authors: millar h. Clin Exp Metastasis. 2008;25(2):139-48. doi: 10.1007/s10585-007-9132-4. Epub 2007 Dec 5. Clin Exp Metastasis. 2008. PMID: 18064530

7

Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage Trogocytosis.

Vijayaraghavan S, Lipfert L, Chevalier K, Bushey BS, Henley B, Lenhart R, Sendecki J, Beqiri M, Millar HJ, Packman K, Lorenzi MV, Laquerre S, Moores SL. Vijayaraghavan S, et al. Mol Cancer Ther. 2020 Oct;19(10):2044-2056. doi: 10.1158/1535-7163.MCT-20-0071. Epub 2020 Aug 3. Mol Cancer Ther. 2020. PMID: 32747419

8

Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies.

Pietsch EC, Dong J, Cardoso R, Zhang X, Chin D, Hawkins R, Dinh T, Zhou M, Strake B, Feng PH, Rocca M, Santos CD, Shan X, Danet-Desnoyers G, Shi F, Kaiser E, Millar HJ, Fenton S, Swanson R, Nemeth JA, Attar RM. Pietsch EC, et al. Among authors: millar hj. Blood Cancer J. 2017 Feb 24;7(2):e536. doi: 10.1038/bcj.2017.7. Blood Cancer J. 2017. PMID: 28234345 Free PMC article.

9

Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity.

Brehmer D, Beke L, Wu T, Millar HJ, Moy C, Sun W, Mannens G, Pande V, Boeckx A, van Heerde E, Nys T, Gustin EM, Verbist B, Zhou L, Fan Y, Bhargava V, Safabakhsh P, Vinken P, Verhulst T, Gilbert A, Rai S, Graubert TA, Pastore F, Fiore D, Gu J, Johnson A, Philippar U, Morschhäuser B, Walker D, De Lange D, Keersmaekers V, Viellevoye M, Diels G, Schepens W, Thuring JW, Meerpoel L, Packman K, Lorenzi MV, Laquerre S. Brehmer D, et al. Among authors: millar hj. Mol Cancer Ther. 2021 Dec;20(12):2317-2328. doi: 10.1158/1535-7163.MCT-21-0367. Epub 2021 Sep 28. Mol Cancer Ther. 2021. PMID: 34583982 Free PMC article.

10

Artificially raised creatinine concentrations due to analytical interference for samples contaminated with total parenteral nutrition fluid.

Jeffery J, Millar H, Marrington R, MacKenzie F, George R. Jeffery J, et al. Among authors: millar h. Ann Clin Biochem. 2024 Jan;61(1):32-38. doi: 10.1177/00045632231186058. Epub 2023 Jul 11. Ann Clin Biochem. 2024. PMID: 37338174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters